Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Panpan Li
Observed name:
李盼盼
Institutions:
Shanghai Medical College of Fudan University,
Northwestern Polytechnical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Northwestern Polytechnical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Zhongshan Hospital
ORCID:
0000-0002-1341-6115
Observed ORCID:
0000-0002-1341-6115
OpenAlex ID:
A5013535187
The evolving diagnosis and treatment paradigms of multiple myeloma in China: 15 years' experience of 1256 patients in a national medical center
2023
·
Yang Yang
, Jing Li
, et al.
·
Cancer Medicine
·
16
PDF
Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma
2023
·
Panpan Li
, Bei Xu
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant
2023
·
Yawen Wang
, Jiadai Xu
, et al.
·
Annals of Hematology
·
8
The role of proliferating stem‐like plasma cells in relapsed or refractory multiple myeloma: Insights from single‐cell RNA sequencing and proteomic analysis
2024
·
Jiadai Xu
, Panpan Li
, et al.
·
British Journal of Haematology
·
6
Update on the outcome of M‐protein screening program of multiple myeloma in China: A 7‐year cohort study
2023
·
Wenjing Wang
, Jing Li
, et al.
·
Cancer Medicine
·
6
PDF
PRUNE1 (located on chromosome 1q21.3) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion
2023
·
Jiadai Xu
, Yawen Wang
, et al.
·
British Journal of Haematology
·
6
Biomimetic Nanoplatform for Targeted Glioblastoma Therapy via Concurrently Triggering GPX4/DHODH Mediated Ferroptosis
2026
·
Guodong Ren
, Xuewei Wang
, et al.
·
Advanced Science
·
4
Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China
2023
·
Liang Ren
, Yuhong Ren
, et al.
·
Hematology
·
4
PDF
The Mechanism Underlying Lenalidomide-Induced Thrombosis Susceptibility
2023
·
Panpan Li
, Bei Xu
, et al.
·
Blood
·
4
“Dual-Boosting” Strategy to Enhance Radical Generation of Photosensitizer for Mitochondria-Targeted Phototherapy
2026
·
Limin Wang
, Dongming Wu
, et al.
·
Research
·
1
Albumin Orchestrates Type‐I ROS Conversion for Efficient Intracellular Bacterial Clearance
2026
·
Bin Fang
, Wenxuan Wang
, et al.
·
Advanced Materials
Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis
2026
·
Yubiao Pan
, Yue Wang
, et al.
·
Hematological Oncology
The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma
2026
·
Jiadai Xu
, Jing Li
, et al.
·
Blood Cancer Journal
PDF
PROTAC-based degradation of catechol-O-methyltransferase for potential treatment of Parkinson’s disease
2026
·
Haixiao Fang
, Panpan Li
, et al.
·
Science China Chemistry
P-404 The Orphan Nuclear Receptor NR5A2 Regulates Phospholipid Remodeling via MBOAT1 and MBOAT2 To Promote Proliferation and Drug Resistance in Multiple Myeloma Cells
2024
·
Panpan Li
, Jiadai Xu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma
2021
·
李盼盼
, 张 卓
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
16
Citation count:
66
H-index:
6
I10-index:
2
Year
Topic
Type